Annual report pursuant to Section 13 and 15(d)

Statements of Cash Flows

v3.22.1
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating activities:    
Net loss $ (4,570,576) $ (1,862,962)
Adjustments required to reconcile net loss to net cash used in operating activities:    
Amortization 3,612 3,609
Stock-based compensation 660,582 677,988
Changes in operating assets and liabilities:    
Accounts payable (526,732) (92,550)
Accrued interest 36,606 73,212
Unreimbursed expenses (accrued) 104,960 47,741
Related party payable
Net cash used in operating activities (4,291,548) (1,152,962)
Financing activities:    
Net proceeds from initial public offering, follow-on offering, exercise of Green Shoe, and exercise of underwriter warrants 3,110,596 30,166,502
Repayment to related party/shareholder (360,000)
Advance from related party/shareholder (275,154)
Net cash provided by (used in) financing activities 2,835,442 29,806,502
Net increase (decrease) in cash (1,456,106) 28,653,540
Cash, beginning of period 28,660,375 6,835
Cash, end of period 27,204,269 28,660,375
Non-cash investing and financing activities:    
Common stock to settle related party payable
Conversion of preferred stock to common 2,023
Issuance of preferred stock due to antidilution $ 42